Immunology & Cancer Therapeutics
Immunology & Cancer Therapeutics is a key segment within the Healthcare sector, comprising 4,793+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Immunology & Cancer Therapeutics companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
mRNA-based therapeutics for diseases including cancer and infections are developed.
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
Targeted and immune-oncology drugs for cancer treatment are developed.
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
Targeted therapies for cancer treatment are developed.
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
Plasma-based biologics are developed for immune deficiency and infectious diseases.
Antibody drugs for cancer treatment are developed.
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Immunotherapeutics for cancer treatment are developed to target solid tumors.
Proprietary antibody-drug conjugates are developed for cancer treatment.
Anti-cancer immunotherapies are developed targeting tumor micro-environment.
Developer of oncolytic immunotherapies
Small molecule therapeutics for inflammatory diseases are developed.
Antibodies are developed for treating cancer, eye, and inflammatory diseases.
Therapies for diverse diseases including oncology are developed.
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
CAR-T and TIL immunotherapies for solid tumors are developed.
T-cell-based immunotherapies for cancer treatment are developed.
Explore Companies in Immunology & Cancer Therapeutics
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies